Table 1 Demographic and clinical data (means ± standard deviation)

From: Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia

Subjects

Number per group

Gendera

Age (years)b

PMI (hours)c

Duration of disease (years)

Age of onset of disease ≤21 (years)

Age of onset of disease >21 (years)

NTR (chlorpromazine equivalents)

Controls

20

11 M/9 F

55.9±13.8

6.0±0.9

    

Schizophrenia

21

10 M/11 F

56.4±17.2

6.6±1.8

26.7±0.8

15.0±2.5

33.20±9.3

416.9±29.8

SPNS

9

4 M/5 F

59.78±18.7

5.83±1.0

31.78±12.9

16.67±2.1

33.83±9.4

487.4±35.6

SPPS

12

5 M/7 F

53.92±16.4

7.13±2.1

26.00±12.2

13.33±1.5

32.78±9.7

360.5±23.5

  1. SPPS the subgroup with predominantly positive symptoms, SPNS the subgroup with predominantly negative symptoms, NTR neuroleptic treatment. Controls vs. SCZ: a Chi-square test (p = 0.43), bANOVA (p = 0.92), cANOVA (p  = 0.24)
Back to article page